First Hawaiian Bank Raises Holdings in Teleflex Incorporated (NYSE:TFX)

First Hawaiian Bank boosted its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 12.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,282 shares of the medical technology company’s stock after buying an additional 487 shares during the quarter. First Hawaiian Bank’s holdings in Teleflex were worth $762,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Cromwell Holdings LLC boosted its stake in Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after acquiring an additional 49 shares in the last quarter. Apollon Wealth Management LLC lifted its stake in shares of Teleflex by 3.7% during the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock worth $377,000 after buying an additional 55 shares during the period. SRS Capital Advisors Inc. lifted its stake in shares of Teleflex by 0.3% during the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock worth $4,844,000 after buying an additional 60 shares during the period. Janney Montgomery Scott LLC lifted its stake in shares of Teleflex by 0.4% during the third quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock worth $3,792,000 after buying an additional 65 shares during the period. Finally, Tokio Marine Asset Management Co. Ltd. lifted its stake in shares of Teleflex by 4.5% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock worth $375,000 after buying an additional 66 shares during the period. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Trading Down 1.8 %

NYSE TFX opened at $174.75 on Friday. Teleflex Incorporated has a 1 year low of $171.69 and a 1 year high of $256.85. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The company has a fifty day moving average of $186.33 and a 200 day moving average of $216.34. The company has a market capitalization of $8.12 billion, a PE ratio of 34.74, a P/E/G ratio of 1.84 and a beta of 1.16.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $764.40 million during the quarter, compared to analysts’ expectations of $768.68 million. During the same quarter in the previous year, the company earned $3.64 earnings per share. The firm’s revenue for the quarter was up 2.4% on a year-over-year basis. Research analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Shareholders of record on Friday, November 15th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.78%. Teleflex’s payout ratio is 27.04%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Truist Financial lowered their price objective on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Royal Bank of Canada decreased their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Finally, Mizuho decreased their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $252.50.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.